DHODH-IN-26
DHODH-IN-26 (compound B2) is a mitochondria-targeting DHODH inhibitor. DHODH-IN-26 shows anticancer activity, triggers the formation of reactive oxygen species (ROS), promots mitochondrial lipid peroxidation, and induces ferroptosis.
For research use only. We do not sell to patients.
- Formula: C44H34BrF2N2O3P
- Molecular Weight:787.63
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
DHODH-IN-26 (compound B2) (0.01-100 μM, 72 h) inhibits cell growth of 4T1, B16F10, U251, GL261, SH-SY5Y, U87, and A375 cells[1].
DHODH-IN-26 (50 and 100 nM) inhibits colony formation in B16F10 and A375 cells[1].
DHODH-IN-26 (50 and 100 nM, 48 h) decreases the expression of PD-L1 in B16F10 and A375 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:4T1, B16F10, U251, GL261, SH-SY5Y, U87, and A375 cells
-
Concentration:0.01, 0.1, 1, 10 and100 μM
-
Incubation Time:72 h
-
Result:Inhibited cell growth.
-
Cell Line:B16F10 and A375 cells
-
Concentration:50 and 100 nM
-
Incubation Time:48 h
-
Result:Decreased the expression of PD-L1.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:B16F10 xenograft model in C57BL/6 mice[1]
-
Dosage:50 mg/kg
-
Administration:I.p.; for 14 days
-
Result:Reduced tumor volume.
Chemical Information
-
Molecular Weight 787.63
-
Formula C44H34BrF2N2O3P
-
SMILES
CC1=C(C2=CC(F)=CC=C2N=C1C3=CC=C(C=C3)C4=CC=C(C=C4F)NC(CC[P+](C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)=O)C(O)=O.[Br-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)